Physician

Jeffrey Nadelson, M.D.

According to 2025 Medicare claims, Jeffrey Nadelson, M.D. (NPI: 1619263399) practices internal medicine in the Providence-Warwick, RI-MA market, with the plurality of this provider's patient population coming from Providence, RI. This provider's primary affiliated billing organization is UNIVERSITY GASTROENTEROLOGY, LLC (NPI: 1386952612; TIN: 273407187) and primary practice location at 02904-2615.

Nadelson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 351 traditional Medicare patients, billed 32,953 HCPCS/CPT codes, and received $345,814 in Medicare payments. The top billing code was 45380 (Biopsy of large bowel using a flexible endoscope). Part D data shows 1,092 prescription claims across 270 beneficiaries totaling $472,715 in drug costs, led by Creon (Lipase/Protease/Amylase). Open Payments data shows 9 records totaling $214. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $28,481 to $345,814. Similarly, Part D prescription costs have risen steadily, from $12,917 to $472,715. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$173K$346K2018 Medicare payment: $28,481 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $53,995 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $61,963 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $73,158 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $95,122 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $276,522 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $345,814 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
20181151,073$28,481
20192483,619$53,995
20202703,641$61,963
20212945,324$73,158
202231811,279$95,122
202340729,139$276,522
202435132,953$345,814

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$240K$479K2015 Drug cost: $12,917 (USD; Tot_Drug_Cst)2016 Drug cost: $62,785 (USD; Tot_Drug_Cst)2017 Drug cost: $398 (USD; Tot_Drug_Cst)2018 Drug cost: $2,382 (USD; Tot_Drug_Cst)2019 Drug cost: $80,175 (USD; Tot_Drug_Cst)2020 Drug cost: $192,439 (USD; Tot_Drug_Cst)2021 Drug cost: $274,356 (USD; Tot_Drug_Cst)2022 Drug cost: $479,380 (USD; Tot_Drug_Cst)2023 Drug cost: $462,901 (USD; Tot_Drug_Cst)2024 Drug cost: $472,715 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152888$12,917
20161431$62,785
20171626$398
20184664$2,382
201996354$80,175
2020126444$192,439
2021177640$274,356
2022232924$479,380
2023232966$462,901
20242701,092$472,715

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
45380Biopsy of large bowel using a flexible endoscope8080$125
99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes4141$101
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4151$90
43239Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope7172$60
91200Measurement of liver stiffness7373$22

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
CreonLipase/Protease/Amylase34910$88,743
ZenpepLipase/Protease/Amylase12330$29,649
LinzessLinaclotide411,650$29,516
MesalamineMesalamine241,354$13,199
Budesonide EcBudesonide12688$5,568

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.9$214Gilead Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jeffrey Nadelson, M.D.?

Tedicare shows public-source Medicare data for Jeffrey Nadelson, M.D. (NPI 1619263399), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jeffrey Nadelson, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jeffrey Nadelson, M.D.?

Jeffrey Nadelson, M.D. is linked to UNIVERSITY GASTROENTEROLOGY, LLC (billing NPI 1386952612) in the available physician profile data.

Does Jeffrey Nadelson, M.D. have Open Payments data?

Jeffrey Nadelson, M.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.